PHIA.AS

$22.83-0.33 (-1.42%)

Market ClosedAs of Mar 20, 4:36 PM UTC

Koninklijke Philips N.V.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$22.83
Potential Downside
20.3%
Whystock Fair Value$18.19
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imagin...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$21.72B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
24.55
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Strong income play. Yield provides a meaningful total return floor.
372.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
7.82%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.90

Recent News

MarketBeat
Mar 20, 2026

Kimball Electronics Maps Medical Pivot, Raises Outlook, Unveils 300,000-Sq-Ft Indianapolis Facility at Forum

Kimball Electronics (NASDAQ:KE) used an appearance at KeyBanc’s sixth annual Healthcare Forum to outline how the contract manufacturer is shifting more of its portfolio toward medical end markets, while also providing an update on recent performance and a new Indianapolis facility designed to suppor

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Mar 18, 2026

Zacks.com featured highlights include Crocs, National Energy Services Reunited and Koninklijke Philips

CROX, NESR and PHG gain on broker upgrades, with strong earnings growth outlooks despite ongoing geopolitical and market uncertainty.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 17, 2026

1 Profitable Stock to Target This Week and 2 We Ignore

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

Buy 3 Stocks With Upgraded Broker Ratings as Geopolitical Woes Linger

CROX, NESR and PHG stand out on broker upgrades as markets stay volatile, signaling potential upside despite geopolitical tensions and shifting investor sentiment.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 16, 2026

Top Research Reports for Philip Morris, Lam Research & Goldman Sachs

Philip Morris, Lam Research and Goldman Sachs lead today's top analyst reports, highlighting smoke-free growth, chip equipment demand and a strategic refocus on core banking.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.